Toward more personalized treatment in prostate cancer: The CCR score predicts metastasis and guides treatment decisions after radiation

28:23 | Apr 29th, 2021

The combined clinical cell-cycle risk (CCR) score uses clinical and genetic factors to assess the risk of metastasis after radiation therapy in patients with prostate cancer. The CCR score has proven ...Show More